Skip to content

Supplementation of serum whey proteins in elderly diabetic type 2 subjects submitted to a program of bodybuilding exercises as a strategy for muscle preservation and blood glucose control: controlled clinical research

Supplementation of whey protein in type 2 diabetic elderly subjects submitted to a resisted exercise program as strategy to preserve lean mass and blood glucose control: a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2s58pz
Enrollment
Unknown
Registered
2018-02-26
Start date
2018-03-12
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Glucose, Muscle, Skeletal, Non-insulin-dependent diabetes mellitus without complications .

Interventions

Recruitment will be recruited 77 voluntiers through personal contact, via telephone, newspaper ads and the internet. Screening All volunteers will undergo a screening process in which the researche
Dietary supplement
Other
G11.427.410.698.277
SP6.051.227

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
65 Years to 89 Years

Inclusion criteria

Inclusion criteria: Volunteers aged 65-89 years; both sexes; good physical and mental condition; creatinine tests less than 3 months within the reference values; To present DM type 2;

Exclusion criteria

Exclusion criteria: Diagnosis of renal and / or hepatic disease;Protein consumption above daily recommendation;Use of medications that interfere with the absorption of amino acids;Use of Insulin; Contraindication for the practice of strength exercises;Practice of resisted exercises.

Design outcomes

Primary

MeasureTime frame
Increased muscle strength, verified by the 1RM test of at least 5% in the pre and post intervention measurements.;Reduction of glycated hemoglobin, verified by blood test of glycated hemoglobin of at least 1.5mg / dl in the pre and post intervention measurements.

Secondary

MeasureTime frame
Improvement of the quality of life (SF-12) with reduction at least 10 points in the pre and post intervention measurements.

Countries

Brazil

Contacts

Public ContactCeline Furtado

Universidade Federal de São Paulo

celine_carvalho@yahoo.com.br+55-13-996169498

Outcome results

None listed

Source: REBEC (via WHO ICTRP)